scholarly article | Q13442814 |
P50 | author | David E. Kleiner | Q41449492 |
Raj Vuppalanchi | Q56427124 | ||
Srinivasan Dasarathy | Q59167255 | ||
Manal F Abdelmalek | Q59194524 | ||
Nonalcoholic Steatohepatitis Clinical Research Network | Q110296507 | ||
Kris V. Kowdley | Q110296712 | ||
P2093 | author name string | Naga Chalasani | |
Arun J Sanyal | |||
Rohit Loomba | |||
Mohammad S Siddiqui | |||
Mark L Van Natta | |||
Brent A Neuschwander-Tetri | |||
Edward Doo | |||
Danielle Brandman | |||
Erin Hallinan | |||
James A Tonascia | |||
P2860 | cites work | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 |
Long-term follow-up of patients with NAFLD and elevated liver enzymes | Q29620024 | ||
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. | Q30382172 | ||
NASH and cryptogenic cirrhosis: a histological analysis. | Q30449747 | ||
Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation | Q34182393 | ||
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Q35893923 | ||
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease | Q36880302 | ||
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease | Q40444861 | ||
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | Q44964478 | ||
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease | Q45024243 | ||
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 | ||
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. | Q53162511 | ||
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis | Q57782665 | ||
Expanding consensus in portal hypertension | Q58034372 | ||
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease | Q58803093 | ||
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease | Q59352709 | ||
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease | Q82648058 | ||
Liver biopsy | Q83395480 | ||
Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B | Q84328358 | ||
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease | Q86582636 | ||
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | steatosis | Q1365091 |
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
fatty liver disease | Q6058862 | ||
P304 | page(s) | 156-163.e2 | |
P577 | publication date | 2018-04-26 | |
P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
P1476 | title | Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease | |
P478 | volume | 17 |
Q104568218 | Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease |
Q58601451 | Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community |
Q90583920 | Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease |
Q91600205 | Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum |
Q104283794 | Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans |
Q92894259 | Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH) |
Q90091780 | Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels |
Q90580674 | Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care |
Q89600297 | Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant |
Q91695771 | Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study |
Q92521100 | Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness |
Q64987408 | Past, present and future perspectives in nonalcoholic fatty liver disease. |
Q91552287 | Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance |
Q90746484 | Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease |
Q91844754 | Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography |
Q100994720 | The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease |
Q90737883 | Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference |
Search more.